+1 (319) 433-6210 contact@medicaldevicesandpharma.com
Medical Devices and Pharma
  • Home
  • Consumer
    • Consumer News
    • Food and Beverage
    • Supplements
  • Regulatory
    • Regulatory Services
    • Medical Devices
    • Pharma
    • Biologics
    • Combination Products
    • Veterinary
  • Quality
    • Quality
    • QSR-to-QMSR
  • News
    • Latest
    • Alerts
  • Contact
Select Page

FDA Approves Treatment for Platinum-Resistant Ovarian Cancer 

by Bruce Waldon | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...

FDA Approves Thoracic Stent Graft System

by David McConkey | Apr 24, 2023 | Consumer Information, FDA Approvals, FDA Public Information, Industry News, Med-Devices, New devices

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Approves RelayPro Thoracic Stent Graft System for Thoracic Aortic Aneurysms and Penetrating Atherosclerotic...

Prodigy Proclaim Spinal Cord Stimulation Systems

by Bruce Waldon | Apr 3, 2023 | Consumer Information, FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Significant advancement for chronic pain treatment On February 15, 2023, the U.S. Food and Drug Administration (FDA)...

FDA Breakthrough Devices Program

by Bruce Waldon | Apr 2, 2023 | Consumer Information, FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation, Reg_Information, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Program assists needed products with access to US market The U.S. Food and Drug Administration (FDA) has established...

FDA Approves Lamzede for Treatment of Alpha-mannosidosis

by David McConkey | Mar 19, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on February 17, 2023 announced the approval the first-ever enzyme...

FDA Approves Rukabia for HIV Treatment

by David McConkey | Mar 16, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on December 22, 2022 announced the approval of a new HIV drug called...
« Older Entries
Next Entries »

QMSR

Regulatory

Quality

Consumer

MDP Facebook page
LinkedIn logo
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}